Active Ingredient Prescribing Mandatory from 1st February

29 January, 2021

Active Ingredient Prescribing will become mandatory from 1st February, 2021

Prepare your practice and download Zedmed Version 33.4.1 to access support for Active Ingredient Prescribing.

Under new medicine regulations, doctors must include the active ingredient names when preparing prescriptions for PBS and RPBS medicines. This means most medicines will be prescribed by their active ingredient, not the brand name. The goal of this initiative is to improve patients understanding of what medications they take and increase the uptake of generic and biosimilar medicines.

The V33.4.1 upgrade file is available in the Zedmed client login section under 'software.'

Please note that the latest MIMS update is required to upgrade your Zedmed and access AIP.

We recommend you utilise an IT professional to perform your Zedmed update and follow the instructions carefully in our Guide to Upgrading Zedmed.

If you need help upgrading your Zedmed, our Support Team are available on 1300 933 000 from Monday to Friday 8:00am-7:00pm and Saturday 9:00am-12:00pm.

To learn more watch our Lunch-n-Learn on Active Ingredient Prescribing below.